)
Create Medic (5187) investor relations material
Create Medic Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Net sales for the six months ended June 30, 2026, increased by 5.6% year-over-year to ¥6,932 million.
Operating profit declined by 38.6% year-over-year to ¥336 million.
Profit attributable to owners of parent dropped 37.0% year-over-year to ¥260 million.
Comprehensive income for the period was ¥814 million, compared to a loss of ¥157 million in the prior year.
Financial highlights
Ordinary profit decreased by 24.2% year-over-year to ¥398 million.
Basic earnings per share for the six months was ¥31.63, down from ¥48.35 year-over-year.
Total assets as of June 30, 2026, stood at ¥20,140 million, nearly unchanged from December 31, 2025.
Net assets increased slightly to ¥16,489 million, with a capital adequacy ratio of 81.9%.
Outlook and guidance
Full-year net sales forecast for 2026 is ¥13,960 million, up 2.5% year-over-year.
Operating profit is projected to decline 24.4% to ¥760 million for the full year.
Profit attributable to owners of parent is expected to decrease 21.5% to ¥560 million.
Basic earnings per share for the year is forecast at ¥68.90.
- Net sales grew 3.8% but profit attributable to owners plunged 98% year-over-year.5187
Q3 202422 Jul 2026 - Net sales rose 4.6% and profit attributable to owners of parent jumped 73.9% year-over-year.5187
Q2 202422 Jul 2026 - Net sales rose 3.5% and net profit surged 446.0% year-over-year, with higher dividends declared.5187
Q4 202422 Jul 2026 - Q1 2025 delivered robust profit growth, but full-year net profit is forecast to decline slightly.5187
Q1 202521 Jul 2026 - Strong first-half profit growth and higher sales, with robust full-year outlook.5187
Q2 202521 Jul 2026 - Sales and operating profit rose, but net income fell; full-year growth and higher dividend expected.5187
Q3 202521 Jul 2026 - Sales and operating profit rose, but net profit fell; moderate growth forecast for FY2026.5187
Q4 202521 Jul 2026 - Q1 2026 delivered higher sales but lower profits, with 2026 guidance signaling profit recovery.5187
Q1 202621 Jul 2026
Next Create Medic earnings date
Next Create Medic earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)